rs681271

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001205293.3(CACNA1E):​c.512+3140G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.614 in 151,692 control chromosomes in the GnomAD database, including 30,884 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 30884 hom., cov: 29)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.69

Publications

3 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.883 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.512+3140G>A intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.512+3140G>A intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.512+3140G>A intron_variant Intron 3 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.512+3140G>A intron_variant Intron 3 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.512+3140G>A intron_variant Intron 3 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.947+3140G>A intron_variant Intron 5 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.614
AC:
93052
AN:
151574
Hom.:
30848
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.498
Gnomad AMR
AF:
0.529
Gnomad ASJ
AF:
0.623
Gnomad EAS
AF:
0.497
Gnomad SAS
AF:
0.590
Gnomad FIN
AF:
0.490
Gnomad MID
AF:
0.615
Gnomad NFE
AF:
0.496
Gnomad OTH
AF:
0.616
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.614
AC:
93136
AN:
151692
Hom.:
30884
Cov.:
29
AF XY:
0.612
AC XY:
45345
AN XY:
74112
show subpopulations
African (AFR)
AF:
0.890
AC:
36836
AN:
41382
American (AMR)
AF:
0.528
AC:
8059
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.623
AC:
2156
AN:
3462
East Asian (EAS)
AF:
0.497
AC:
2542
AN:
5116
South Asian (SAS)
AF:
0.588
AC:
2803
AN:
4770
European-Finnish (FIN)
AF:
0.490
AC:
5166
AN:
10542
Middle Eastern (MID)
AF:
0.610
AC:
178
AN:
292
European-Non Finnish (NFE)
AF:
0.496
AC:
33656
AN:
67860
Other (OTH)
AF:
0.611
AC:
1289
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1573
3145
4718
6290
7863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.532
Hom.:
84016
Bravo
AF:
0.630
Asia WGS
AF:
0.524
AC:
1824
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
15
DANN
Benign
0.75
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs681271; hg19: chr1-181483786; API